These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18316024)

  • 1. Look who's talking: nuclear receptors in the liver and gastrointestinal tract.
    Downes M; Liddle C
    Cell Metab; 2008 Mar; 7(3):195-9. PubMed ID: 18316024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editor's Highlight: Clofibrate Decreases Bile Acids in Livers of Male Mice by Increasing Biliary Bile Acid Excretion in a PPARα-Dependent Manner.
    Zhang Y; Lickteig AJ; Csanaky IL; Klaassen CD
    Toxicol Sci; 2017 Dec; 160(2):351-360. PubMed ID: 28973556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Farnesoid X Receptor as Target for Therapies to Treat Cholestasis-Induced Liver Injury.
    Petrescu AD; DeMorrow S
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile Acids in Cholestasis and its Treatment.
    Arab JP; Cabrera D; Arrese M
    Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s53-s57. PubMed ID: 29080340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear receptors and cholesterol metabolism in the intestine.
    Moschetta A
    Atheroscler Suppl; 2015 Feb; 17():9-11. PubMed ID: 25659870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury.
    Stedman CA; Liddle C; Coulter SA; Sonoda J; Alvarez JG; Moore DD; Evans RM; Downes M
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2063-8. PubMed ID: 15684063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist.
    Sayin SI; Wahlström A; Felin J; Jäntti S; Marschall HU; Bamberg K; Angelin B; Hyötyläinen T; Orešič M; Bäckhed F
    Cell Metab; 2013 Feb; 17(2):225-35. PubMed ID: 23395169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-talk between bile acids and gastrointestinal tract for progression and development of cancer and its therapeutic implications.
    Kundu S; Kumar S; Bajaj A
    IUBMB Life; 2015 Jul; 67(7):514-23. PubMed ID: 26177921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered enterohepatic circulation of bile acids in Crohn's disease and their clinical significance: a new perspective.
    Nolan JD; Johnston IM; Walters JR
    Expert Rev Gastroenterol Hepatol; 2013 Jan; 7(1):49-56. PubMed ID: 23265149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear receptors, bile-acid detoxification, and cholestasis.
    Chen J; Raymond K
    Lancet; 2006 Feb; 367(9509):454-6. PubMed ID: 16473109
    [No Abstract]   [Full Text] [Related]  

  • 11. PXR- and CAR-mediated herbal effect on human diseases.
    Xu C; Huang M; Bi H
    Biochim Biophys Acta; 2016 Sep; 1859(9):1121-1129. PubMed ID: 26906544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis.
    Fiévet C; Staels B
    Biochem Pharmacol; 2009 Apr; 77(8):1316-27. PubMed ID: 19101522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear receptors, inflammation, and liver disease: insights for cholestatic and fatty liver diseases.
    Arrese M; Karpen SJ
    Clin Pharmacol Ther; 2010 Apr; 87(4):473-8. PubMed ID: 20200515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism: A lipid for fat disorders.
    Ingraham HA
    Nature; 2011 Jun; 474(7352):455-6. PubMed ID: 21697939
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis.
    Inagaki T; Choi M; Moschetta A; Peng L; Cummins CL; McDonald JG; Luo G; Jones SA; Goodwin B; Richardson JA; Gerard RD; Repa JJ; Mangelsdorf DJ; Kliewer SA
    Cell Metab; 2005 Oct; 2(4):217-25. PubMed ID: 16213224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of bile acid synthesis by the nuclear receptor Rev-erbalpha.
    Duez H; van der Veen JN; Duhem C; Pourcet B; Touvier T; Fontaine C; Derudas B; Baugé E; Havinga R; Bloks VW; Wolters H; van der Sluijs FH; Vennström B; Kuipers F; Staels B
    Gastroenterology; 2008 Aug; 135(2):689-98. PubMed ID: 18565334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile acids and their nuclear receptor FXR: Relevance for hepatobiliary and gastrointestinal disease.
    Gadaleta RM; van Mil SW; Oldenburg B; Siersema PD; Klomp LW; van Erpecum KJ
    Biochim Biophys Acta; 2010 Jul; 1801(7):683-92. PubMed ID: 20399894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear receptors. I. Nuclear receptors and bile acid homeostasis.
    Goodwin B; Kliewer SA
    Am J Physiol Gastrointest Liver Physiol; 2002 Jun; 282(6):G926-31. PubMed ID: 12016116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis.
    Meng Q; Chen XL; Wang CY; Liu Q; Sun HJ; Sun PY; Huo XK; Liu ZH; Yao JH; Liu KX
    Toxicol Appl Pharmacol; 2015 Mar; 283(3):178-86. PubMed ID: 25655198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting farnesoid X receptor for liver and metabolic disorders.
    Fiorucci S; Rizzo G; Donini A; Distrutti E; Santucci L
    Trends Mol Med; 2007 Jul; 13(7):298-309. PubMed ID: 17588816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.